Waterstone Pharmaceuticals, Inc. is a key player in the global life sciences industry, based in Indianapolis, IN with operations in Wuhan, China. The company, founded in 2008, focuses on providing a wide range of products and services to the pharmaceutical industry. This includes an extensive catalog of over 30,000 research products, custom synthesis, development and manufacturing, as well as non GMP and cGMP advanced starting materials and APIs. In 2010, Waterstone Pharmaceuticals made significant strides by launching a new R&D center and API manufacturing facility, aligning with ICH Q7 and US FDA cGMP guidelines. It's also noteworthy that the company secured a $19.00M Debt Financing investment on 26 September 2012. This indicates a strong financial backing and investor confidence in the company's capabilities and potential for growth. With its focus on technological advancements and capacity-building, Waterstone Pharmaceuticals is well-positioned to continue serving and shaping the pharmaceutical industry on a global scale.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $19.00M | - | 26 Sep 2012 | |
| Series B | $3.39M | 2 |
|
21 Aug 2012 |
No recent news or press coverage available for Waterstone Pharmaceuticals, Inc..
We care about your data, and we'd love to use cookies make your experience better.
